CLINICAL TRIALS PROFILE FOR CAMOQUIN HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for CAMOQUIN HYDROCHLORIDE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00356824 ↗ | Relationship Between HIV and Malaria in Ugandan Children | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-11-01 | HIV and malaria are two of the most important diseases to afflict children in sub-Saharan Africa. However, it is unknown what relationships exist between the two diseases. The purpose of this study is to determine the relationship between HIV and malaria infections in HIV infected Ugandan children. | |
NCT00859807 ↗ | A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects | Completed | Pfizer | Phase 4 | 2009-05-01 | The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis). |
NCT00894660 ↗ | A Bioequivalence Study Comparing Amodiaquine Tablet (Pfizer) To Amodiaquine Tablets (Arsuamoon-Guilin China) In Healthy Subjects | Completed | Pfizer | Phase 1 | 2009-06-01 | The study will determine if amodiaquine tablet (Pfizer), an antimalaria agent, is pharmaceutically equivalent to a comparator product (Arsuamoon-Guilin China). |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CAMOQUIN HYDROCHLORIDE
Condition Name
Clinical Trial Locations for CAMOQUIN HYDROCHLORIDE
Clinical Trial Progress for CAMOQUIN HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for CAMOQUIN HYDROCHLORIDE
Sponsor Name